Sign in

CIK 0001133416

  • Non-accelerated filer
  • Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
043562325
Phone
+1 678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
  1. 4 Open-market buy Director bought 1,300 shares at $2.64 ($3,432)
  2. 4 Open-market buy Director bought 10,000 shares at $2.70 ($27,000)
  3. 4 Open-market buy Director bought 3,500 shares at $2.30 ($8,050)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4/A Open-market buy Director bought 400 shares at $2.39 ($956)
  7. 4 Open-market buy Director bought 400 shares at $2.39 ($956)
  8. 4 Open-market buy Director bought 2,500 shares at $2.38 ($5,950)
  9. 4 Open-market buy Director bought 1,000 shares at $3.52 ($3,520)
  10. 4 Open-market buy President and CEO bought 1,000 shares at $3.39 ($3,390)
  11. 5 Insider Annual Insider Trading Report
  12. 4 Open-market sale 10% owner sold 25,000 shares at $3.06 ($76,500)
  13. 4 Open-market buy Director bought 2,500 shares at $2.98 ($7,450)
  14. 4 Other acquisition Director acquired 2,063 shares (code W)
  15. 4 Grant or award President and CEO acquired 152,584 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award Director acquired 23,256 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 39 · 776 filings